Previous Close | 51.05 |
Open | 51.07 |
Bid | 50.69 x 1000 |
Ask | 53.39 x 1000 |
Day's Range | 50.49 - 51.57 |
52 Week Range | 43.04 - 66.14 |
Volume | |
Avg. Volume | 508,393 |
Market Cap | 2.801B |
Beta (5Y Monthly) | 2.07 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.
Enovis (ENOV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.